| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |